This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. Waters Division (88.8% of total revenues in 2019) - High Performance and Ultra Performance Liquid Chromatography (HPLC and UPLC). TA Division (11.2% of total revenues in 2019)- Thermal Analysis, Rheometry and Calorimetry.
Waters (WAT) Down 6.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q4 Earnings Surpass Estimates, Sales Rise Y/Y
by Zacks Equity Research
Waters' (WAT) fourth-quarter results reflect gains from strong momentum across the industrial end and strong performances in the Americas.
Waters (WAT) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 2.67% and 3.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Waters' (WAT) fourth-quarter 2022 results are likely to reflect strength in liquid chromatography instruments and mass spectrometers, and solid end-market momentum.
PerkinElmer (PKI) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
PerkinElmer (PKI) delivered earnings and revenue surprises of 2.41% and 1.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Mettler-Toledo (MTD) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 4.04% and 3.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Waters (WAT) Could Beat Earnings Estimates Again
by Zacks Equity Research
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights ASML Holding, Impinj, MSCI, Udemy and Waters
by Zacks Equity Research
ASML Holding, Impinj, MSCI, Udemy and Waters are part of the Zacks top Analyst Blog.
5 Technology Stocks Set to Top Estimates This Earnings Season
by Shilpa Mete
Here's a sneak peek into five technology stocks, which hold the potential to surpass fourth-quarter 2022 estimates.
Zacks Industry Outlook Highlights Mettler-Toledo, PerkinElmer and Waters
by Zacks Equity Research
Mettler-Toledo, PerkinElmer and Waters have been highlighted in this Industry Outlook article.
3 Instruments Stocks to Watch From a Challenging Industry
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand despite lingering effects of COVID-19.
Why Is PerkinElmer (PKI) Up 10.3% Since Last Earnings Report?
by Zacks Equity Research
PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Up 17.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q3 Earnings Surpass Estimates, Sales Rise Y/Y
by Zacks Equity Research
Waters' (WAT) third-quarter results reflect gains from strong momentum across the industrial, government and academic end markets.
Waters (WAT) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 2.72% and 4.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Waters' (WAT) third-quarter 2022 results are likely to reflect the impacts of product portfolio strength and large molecule momentum.
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Waters (WAT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Mettler-Toledo, PerkinElmer and Waters
by Zacks Equity Research
Mettler-Toledo, PerkinElmer and Waters have been highlighted in this Industry Outlook article.
Waters (WAT) to Attract Scientists With Extraction+ Device
by Zacks Equity Research
Waters (WAT) unveils the Extraction+ Connected Device for the Waters Andrew+ Pipetting Robot. The device automates solid phase extraction methods, saving bench time for each sample set.
3 Stocks to Watch on Rising Demand for Scientific Instruments
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), Waters (WAT) and PerkinElmer (PKI) are gaining from strong life science, pharmaceutical and academic end-market demand, as well as rising healthcare spending.
Why Is Waters (WAT) Down 11.9% Since Last Earnings Report?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q2 Earnings & Sales Surpass Estimates, Rise Y/Y
by Zacks Equity Research
Waters' (WAT) second-quarter results reflect gains from a strong momentum across pharmaceutical and industrial end-markets, and geographical regions.
Waters (WAT) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 4.56% and 1.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Waters' (WAT) second-quarter 2022 results are likely to reflect solid momentum in the pharmaceutical, industrial, and the academic and government end markets.